[nerd project]
[ai]September 27, 2026 2 min read

Insurers Claim AI Is Already Driving Up Healthcare Costs

Insurers Claim AI Is Already Driving Up Healthcare Costs

Photo via Unsplash

AI in healthcare is already increasing costs, according to Blue Cross Blue Shield. The insurer claims that hospital use of AI tools led to an additional $942 million in spending over a two-year period. That’s a troubling data point for a technology sold as a way to make medicine cheaper and smarter.

The Background: A Promise of Efficiency

Hospitals have rushed to adopt AI in healthcare—algorithms for triage, coding, diagnosis, and workflow. The pitch was simple: fewer errors, faster decisions, lower costs. But the U.S. payment system rewards volume, not value. When a tool suggests more tests or treatments, it can inflate the bill rather than shrink it. That misalignment has been lurking for years; now we have a number attached.

The Details: $942 Million Over Two Years

Blue Cross Blue Shield analyzed claims data and found a correlation between hospital AI use and higher spending. The total: $942 million in additional costs over two years. The insurer didn’t name specific hospitals or tools, but the pattern is clear. AI-assisted decisions are generating more interventions, not fewer. And those interventions get billed. This isn’t a rounding error—it’s a systemic effect. The report suggests the technology is adding cost, not replacing it.

The Analysis: Who Wins, Who Loses

Hospitals and AI vendors win: more procedures, more revenue. Insurers lose, and they pass that cost to premiums. Patients ultimately pay. My take: AI in healthcare isn’t neutral; it amplifies existing incentives. Without payment reform, the tech that promised savings becomes a cost engine. This isn’t an AI failure—it’s a failure of the system that adopted it.

The Implications: Pressure to Regulate

This finding will likely accelerate calls to regulate AI in hospitals. Insurers may demand algorithm audits or refuse to cover AI-driven decisions. Scrutiny on the FDA and other regulators will grow. The key question: how do you measure the value of a tool that increases costs but improves outcomes? Without clear metrics, the debate stays stuck.

In the end, AI isn’t the problem or the solution—it’s a mirror reflecting what healthcare already was.

Source: TechCrunch

#IA en salud#costos de salud#seguros médicos#tecnología sanitaria

[weekly newsletter]

Top 10 tech stories every Monday. No spam.

subscribe →
Leer en español: Versión en español →
share:WhatsAppTelegram𝕏

[comments]

1000 chars left